Back to search
FDAFDA · Food and drugs·Recall number Z-1700-2015

Swan-Ganz CCO/Sv02/CEDV/VIP Thermodilution Catheters model number 744HF75. Flow-directed pulmonary artery catheters for monitoring cardiac output, mixed venous oxygen saturation, and end diastolic volume when used with the Vigilance Monitor.

Published June 10, 2015 · Recall initiated: May 5, 2015

Summary

FDA records medical device Class II recall Z-1700-2015, published June 10, 2015 and initiated May 5, 2015. Recalling firm: Edwards Lifesciences, LLC; Status: Terminated; Reported quantity: 978; Lot: lot number 59860969. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The product failed to meet the internal established statistical test requirement for heparin activity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Edwards Lifesciences, LLC
Distributor
Worldwide distribution US nationwide, Canada and Europe (IC, BE, IT, GB, FR, DK, CZ, DE, AT, ES, IE, NO, PL)
Lot
lot number 59860969.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Swan-Ganz CCO/Sv02/CEDV/VIP Thermodilution Catheters model number 744HF75. Flow-directed pulmonary artery catheters for monitoring cardiac output, mixed venous oxygen saturation, and end diastolic volume when used with the Vigilance Monitor. recalled?

Yes. FDA published recall Z-1700-2015 on June 10, 2015. Reported hazard: The product failed to meet the internal established statistical test requirement for heparin activity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter